Drug intelligence / Profile preview

Xiasadexi

Development stage: Unknown
Lead developer: Zang Hospital of Ruoergai County
Modality: Small Molecules
Administration: Oral

Overview

Xiasadexi is a traditional Tibetan medicine (Zang medicine) hospital preparation developed by the Zang Hospital of Ruoergai County in Sichuan Province, China. It is specifically formulated for the treatment of chronic superficial gastritis. As a traditional multi-ingredient preparation, it aims to regulate gastric function and alleviate symptoms such as epigastric pain, bloating, and acid reflux by reducing inflammation of the gastric mucosa. In Tibetan medical theory, it is often employed to treat "stomach heat" and digestive imbalances. The preparation is registered as a hospital-specific medication (院内制剂) and is used within the regional healthcare system of Sichuan.

Brand names: Xiasadexi
Other names: 夏萨德西Xiasa Dexi

Beyond the preview

Go deeper on Xiasadexi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiasadexi.

Explore the full profile